DEA to Reclassify Marijuana as Less Dangerous Drug, Sources Say

The U.S. Drug Enforcement Administration (DEA) is set to make a historic shift in American drug policy by reclassifying marijuana as a less dangerous drug. This move, which has been confirmed by five anonymous sources familiar with the matter, would recognize the medical uses of cannabis and acknowledge its lower potential for abuse compared to other dangerous drugs.

The proposal, which still needs to be reviewed by the White House Office of Management and Budget, would move marijuana from its current classification as a Schedule I drug, alongside heroin and LSD, to Schedule III, alongside ketamine and some anabolic steroids. This decision follows a recommendation from the federal Health and Human Services Department.

Attorney General Merrick Garland’s signature on the proposal signals the importance of this move to the Biden administration. President Joe Biden has been advocating for a review of federal marijuana laws and has already taken steps to pardon thousands of Americans convicted of simple possession of the drug.

The announcement could help boost support for Biden, particularly among younger voters, as public opinion on marijuana legalization has been steadily increasing. However, critics argue that rescheduling marijuana is unnecessary and could have harmful side effects, while others believe it should be treated similarly to alcohol.

While the immediate impact on the criminal justice system may be limited, easing federal regulations on marijuana could have far-reaching consequences. The marijuana industry, estimated to be worth nearly $30 billion, could benefit from reduced tax burdens and easier access to research opportunities.

Despite these potential benefits, challenges remain, including the need for cannabis dispensaries to register with the DEA and comply with strict reporting requirements. Additionally, the U.S. is bound by international treaty obligations that require the criminalization of cannabis, posing a potential obstacle to the DEA’s decision.

Overall, the DEA’s move to reclassify marijuana represents a significant shift in drug policy that could have wide-ranging effects on the country. Stay tuned for updates as the proposal moves through the formal rulemaking process.